Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.111 CHF
1.32 B CHF
16.46 B CHF
442.48 M
About GE HealthCare Technologies Inc.
Sector
Industry
CEO
Peter J. Arduini
Website
Headquarters
Chicago
Founded
1892
FIGI
BBG01C83JBG5
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company’s history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
GE5501817
GE Healthcare Technologies Inc. 5.6% 15-NOV-2025Yield to maturity
10.61%
Maturity date
Nov 15, 2025
GE5591354
GE Healthcare Technologies Inc. 6.377% 22-NOV-2052Yield to maturity
5.53%
Maturity date
Nov 22, 2052
GE5501821
GE Healthcare Technologies Inc. 6.377% 22-NOV-2052Yield to maturity
5.52%
Maturity date
Nov 22, 2052
GE5501816
GE Healthcare Technologies Inc. 5.6% 15-NOV-2025Yield to maturity
5.47%
Maturity date
Nov 15, 2025
GE5501819
GE Healthcare Technologies Inc. 5.857% 15-MAR-2030Yield to maturity
5.37%
Maturity date
Mar 15, 2030
GE5501722
GE Healthcare Technologies Inc. 5.905% 22-NOV-2032Yield to maturity
5.21%
Maturity date
Nov 22, 2032
GE5591353
GE Healthcare Technologies Inc. 5.905% 22-NOV-2032Yield to maturity
5.11%
Maturity date
Nov 22, 2032
GE5501813
GE Healthcare Technologies Inc. 5.65% 15-NOV-2027Yield to maturity
5.08%
Maturity date
Nov 15, 2027
GEHCV5868518
GE Healthcare Technologies Inc. 4.8% 14-AUG-2029Yield to maturity
5.05%
Maturity date
Aug 14, 2029
Explore more bonds
Frequently Asked Questions
The current price of L0T is 72.039 CHF — it has decreased by −0.81% in the past 24 hours. Watch GE HEALTHCARE TECH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange GE HEALTHCARE TECH stocks are traded under the ticker L0T.
L0T stock has risen by 1.34% compared to the previous week, the month change is a −3.99% fall, over the last year GE HEALTHCARE TECH has showed a 9.97% increase.
We've gathered analysts' opinions on GE HEALTHCARE TECH future price: according to them, L0T price has a max estimate of 98.29 CHF and a min estimate of 66.12 CHF. Watch L0T chart and read a more detailed GE HEALTHCARE TECH stock forecast: see what analysts think of GE HEALTHCARE TECH and suggest that you do with its stocks.
L0T stock is 0.81% volatile and has beta coefficient of 0.43. Track GE HEALTHCARE TECH stock price on the chart and check out the list of the most volatile stocks — is GE HEALTHCARE TECH there?
Today GE HEALTHCARE TECH has the market capitalization of 32.41 B, it has increased by 0.65% over the last week.
Yes, you can track GE HEALTHCARE TECH financials in yearly and quarterly reports right on TradingView.
GE HEALTHCARE TECH is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
L0T earnings for the last quarter are 0.97 CHF per share, whereas the estimation was 0.89 CHF resulting in a 8.32% surprise. The estimated earnings for the next quarter are 1.14 CHF per share. See more details about GE HEALTHCARE TECH earnings.
GE HEALTHCARE TECH revenue for the last quarter amounts to 4.12 B CHF, despite the estimated figure of 4.13 B CHF. In the next quarter, revenue is expected to reach 4.80 B CHF.
L0T net income for the last quarter is 399.14 M CHF, while the quarter before that showed 384.79 M CHF of net income which accounts for 3.73% change. Track more GE HEALTHCARE TECH financial stats to get the full picture.
Yes, L0T dividends are paid quarterly. The last dividend per share was 0.03 CHF. As of today, Dividend Yield (TTM)% is 0.15%. Tracking GE HEALTHCARE TECH dividends might help you take more informed decisions.
GE HEALTHCARE TECH dividend yield was 0.16% in 2023, and payout ratio reached 3.97%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 21, 2024, the company has 51.00 K employees. See our rating of the largest employees — is GE HEALTHCARE TECH on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GE HEALTHCARE TECH EBITDA is 2.91 B CHF, and current EBITDA margin is 17.38%. See more stats in GE HEALTHCARE TECH financial statements.
Like other stocks, L0T shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GE HEALTHCARE TECH stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GE HEALTHCARE TECH technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GE HEALTHCARE TECH stock shows the neutral signal. See more of GE HEALTHCARE TECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.